AI assistant
Sending…
BIO-RAD LABORATORIES, INC. — Director's Dealing 2011
Jun 14, 2011
30786_dirs_2011-06-14_7c2119a8-7169-4a2e-89d9-bb40f03f7d67.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIO RAD LABORATORIES INC (BIO, BIO.B)
CIK: 0000012208
Period of Report: 2011-06-10
Reporting Person: TSINGOS CHRISTINE A (CFO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2011-06-10 | Bio-Rad A Common Stock | M | 200 | — | Acquired | 3535.0979 | Direct |
| 2011-06-13 | Bio-Rad A Common Stock | S | 74 | $117.30 | Disposed | 3461.0979 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2011-06-10 | Restricted Stock Units | $ | M | 200 | Disposed | Bio-Rad A Common Stock (200) | Direct |
Footnotes
F1: Shares of Class A common stock acquired on the vesting of restricted stock units.
F2: Sold by the Issuer on behalf of the Reporting Person to satisfy certain tax obligations in connection with the vesting of restricted stock units, all in accordance with a restricted stock unit award agreement.
F3: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.
F4: The restriced stock units vest in five equal annual installments beginning June 10, 2010.
More from BIO-RAD LABORATORIES, INC.
Regulatory Filings
2026
May 13
Regulatory Filings
2026
Apr 30
Interim / Quarterly Report
2026
Apr 30
Regulatory Filings
2026
Apr 30
Regulatory Filings
2026
Apr 24
Major Shareholding Notification
2026
Mar 26
Annual Report
2026
Mar 25
Proxy Solicitation & Information Statement
2026
Mar 25
Regulatory Filings
2026
Feb 19
Annual Report
2026
Feb 13